Progress in study of leflunomide in treatment of rheumatoid arthritis
HU Jin-hong
LU Sui-feng
ZHU Quan-gang
SUN Hua-jun
XIAO Fei
Abstract:Leflunomide is the first drug to modify the process of rheumatoid arthritis(RA) with special mechanism of action.Foreign and domestic clinical trials have revealed that leflunomide is more effective for treatment of RA with mild and less adverse events and that it can effectively control the development of RA;retard the damage of bone and joints;and improve the patients' quality of life.It represents an effective drug for treatment of RA.
Machine-generated Keywords:
Publication Date:2001-01-01
Online Publishing Date:2026-08-14(First online date of this platform, not the publication date of the document)
Pages:7( 294-300 )
CHINESE JOURNAL OF NEW DRUGS

CHINESE JOURNAL OF NEW DRUGS

PKUISTIC
ISSN:1003-3734
Year, Vol.(Issue):2001,10(4)